查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1603889

到 2030 年马医疗保健市场预测：按产品类型、动物类型、疾病类型、分销管道、最终用户和地区进行的全球分析

Equine Healthcare Market Forecasts to 2030 - Global Analysis By Product Type (Therapeutics, Diagnostics, Supplemental Nutrition and Other Product Types), Animal Type, Disease Type, Distribution Channel, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2024 年全球马保健品市场规模将达到 36 亿美元，预计到 2030 年将达到 65 亿美元，预测期内复合年增长率为 10.3%。

马匹保健是一门透过医疗、营养和管理实践关注马匹健康和福祉的专业。常规兽医护理包括疫苗接种和牙科检查，以预防绞痛、蹄叶炎和呼吸道感染疾病等常见疾病。蹄铁匠对马蹄进行适当的护理可确保您的马的活动能力并降低跛行的风险。我们根据年龄、活动量和健康状况提供均衡的干草、谷物和补充品组合的客製化膳食。运动管理对于健身、心理健康和预防伤害至关重要。马匹保健也涉及生殖健康，协助繁殖、怀孕和马驹护理。

据 2024 年 2 月《欧洲新闻》新闻稿称，哥斯达黎加科学家正在参与研究和开发人类蛇咬伤的解毒剂。他们利用马作为容器来开发疫苗抗体。

马疾病增加

由于马匹疾病的增加以及对兽医护理、诊断和治疗的相关需求，针对马匹的医疗保健服务正在增加。医院和兽医诊所患者数量的增加是这项需求的主要驱动力。由于马病发病率不断上升，以及对血液检测、影像检查和基因检测等精确诊断方法的需求，对先进诊断技术的需求也很高。

农村地区获得兽医护理的机会有限

由于农村地区获得兽医服务的机会有限，寻求定期治疗的马主越来越少。这导致对马保健产品和服务的需求较低，限制了市场渗透率。此外，未经治疗的疾病可能无法确诊并导致感染疾病和严重症状。恢復需要更长的时间，医疗费用也会增加。因此，及时的兽医干预对于缓解这些问题并提高这些地区马匹的整体生活品质至关重要。

提升马主和兽医对马匹健康的认识

人们对马健康问题的认识不断提高，导致马主寻求兽医服务的趋势不断增加。因此，对定期检查、疫苗接种和专门治疗的需求不断增加。随着越来越多的马主优先考虑马匹的健康，常规疫苗接种和寄生虫控制等预防性护理市场预计将会成长。人们对预防措施的兴趣日益浓厚，促进了疫苗、诊断工具和其他旨在维持马匹健康的医疗保健产品市场的成长。

缺乏熟练的兽医

随着执业马兽医数量的减少，马主很难得到及时的兽医护理。许多诊所都在努力接受新客户，预约和紧急服务的等待时间很长。这种有限的获取机会导致健康问题不受治疗，对马匹福利产生负面影响，增加严重健康併发症的风险，并阻碍市场成长。

COVID-19 的影响

COVID-19大流行显着加速了各领域对服务机器人的需求。为了最大限度地减少人际接触并保持业务连续性，机器人迅速被引入医疗保健、物流和消毒服务领域。在仓库和零售业，机器人回应了日益增长的电子商务需求。这一激增凸显了机器人在提高效率和安全性方面的价值，促进了疫情后服务机器人的长期投资和创新。

预计治疗领域在预测期内将是最大的

由于越来越多地采用抗感染药、疫苗、止痛药和再生疗法，治疗领域估计是最大的。这一增长是由马主和设施对疾病预防和治疗方案的投资增加所推动的。治疗方法在疾病控制和预防、支持牛健康和减少代价高昂的疫情爆发方面也发挥着重要作用。

预计莱姆病产业在预测期内复合年增长率最高

由于马莱姆病需要复杂的诊断程序，包括 ELISA 等血清学测定以及蛋白质印迹和萤光测定等验证测试，因此莱姆病部分预计在预测期内出现最高的复合年增长率。马莱姆病多重检测等先进诊断工具可提高早期检测和准确性，这对于有效治疗至关重要。因此，对全面诊断服务的需求以及马主对莱姆病认识的提高正在推动市场的成长。

比最大的地区

由于该地区（尤其是中国、日本和澳洲）马术比赛的快速增长，导致对马保健产品的需求不断增加，预计亚太地区将在预测期内占据最大的市场占有率。这项需求的推动因素是赛马、马术障碍赛和马球运动的参与度增加，以及疫苗、抗感染剂和补充品等解决常见马匹健康问题的重要性，这是因为性取向正在增加。

复合年增长率最高的地区：

预计北美在预测期内的复合年增长率最高。北美强大的兽医基础设施为马术专家、诊所和医院提供了便利。透过提供专业、高品质的护理，市场正在不断扩大。对破伤风、马流感和西尼罗河病毒等马疾病的需求不断增加，也推动了对疫苗、驱虫产品和补充品等预防性治疗的大量投资。

免费客製化服务：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场公司的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争标基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究资讯来源
    • 主要研究资讯来源
    • 二次研究资讯来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 最终用户分析
  • 新兴市场
  • COVID-19 的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球马保健市场：依产品类型

  • 治疗药物
    • 疫苗
    • 抗感染剂
    • 寄生剂
    • 发炎药
  • 诊断
    • 临床病理学
    • 免疫检测
    • 分子诊断
    • 影像技术
  • 食品补充品
    • 饲料添加剂
    • 表现补充品
  • 其他产品类型

第六章全球马保健市场：依动物类型

  • 比赛马
  • 休閒马
  • 工作马
  • 赛马
  • 其他动物类型

第七章全球马医疗保健市场：依疾病类型

  • 马流感
  • 莱姆病
  • 破伤风
  • 狂犬病
  • 马脑脊髓炎
  • 肌肉骨骼疾病
  • 西尼罗病毒
  • 狂犬病
  • 其他类型的疾病

第八章全球马保健市场：依通路分类

  • 动物医院/诊所
  • 电子商务
  • 零售药局/药局
  • 其他分销管道

第九章全球马医疗保健市场：依最终用户分类

  • 动物医院
  • 动物诊所
  • 调查机构
  • 其他最终用户

第十章全球马保健市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第十一章 主要进展

  • 合约、伙伴关係、合作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务拓展
  • 其他关键策略

第十二章 公司概况

  • Arthrex Inc.
  • Boehringer Ingelheim International GmbH
  • Cargill
  • Ceva Sante Animale
  • Covetrus Inc.
  • Dechra Pharmaceuticals
  • Elanco
  • Esaote SPA
  • Hallmarq Veterinary Imaging
  • Heska Corporation
  • IDEXX Laboratories, Inc.
  • Kyoritsuseiyaku Corporation
  • Merck & Co. Inc
  • Neogen Corporation
  • Purina Animal Nutrition LLC.
  • Vetoquinol SA
  • Zoetis
Product Code: SMRC27911

According to Stratistics MRC, the Global Equine Healthcare Market is accounted for $3.6 billion in 2024 and is expected to reach $6.5 billion by 2030 growing at a CAGR of 10.3% during the forecast period. Equine healthcare is a specialized field that focuses on the health and well-being of horses through medical care, nutrition, and management practices. It includes routine veterinary care, such as vaccinations and dental exams, to prevent common diseases like colic, laminitis, and respiratory infections. Proper hoof care by farriers ensures horses' mobility and reduces lameness risk. Nutrition is a core component, with tailored diets balancing hay, grains, and supplements based on age, activity level, and health status. Exercise management is crucial for fitness, mental well-being, and injury prevention. Equine healthcare also addresses reproductive health, assisting with breeding, pregnancy, and foal care.

According to a February 2024 press release by Euro News, scientists from Costa Rica are involved in R&D to develop antidotes for human snake bites. They are utilizing the horses as the vessels to develop antibodies against the vaccine.

Market Dynamics:

Driver:

Rising incidence of equine diseases

Specialized horse healthcare services have increased as a result of the rise in equine diseases and the resulting demand for veterinary care, diagnosis, and treatments. Increased patient loads in hospitals and veterinary clinics are the main cause of this demand. Advanced diagnostic technologies are also in high demand due to the rising incidence of horse diseases and the need for precise diagnostic methods such blood tests, imaging tests, and genetic testing.

Restraint:

Limited access to veterinary care in rural areas

Rural areas lack access to veterinary services, resulting in fewer horse owners seeking regular care. This leads to a lower demand for equine healthcare products and services, limiting market penetration. Untreated diseases can also go undiagnosed or untreated, causing infections and severe conditions. Long recovery times and increased healthcare costs can be exacerbated. Therefore, timely veterinary intervention is crucial to mitigate these issues and improve the overall quality of life for horses in these areas.

Opportunity:

Heightened awareness regarding equine health among horse owners and veterinarians

Horse owners are increasingly seeking veterinary services due to increased awareness about equine health issues. This leads to a higher demand for routine check-ups, vaccinations, and specialized treatments. The market for preventive care, such as regular vaccinations and parasite control, is expected to grow as more horse owners prioritize their animals' health. This increased focus on preventive measures contributes to the growth of the market for vaccines, diagnostic tools, and other healthcare products designed to maintain equine health.

Threat:

Shortage of skilled veterinarians

As the number of practicing equine veterinarians decreases, horse owners face increasing difficulties in accessing timely veterinary care. Many clinics struggle to accommodate new clients, leading to longer wait times for appointments and emergency services. This limited access can result in untreated health issues, negatively impacting horse welfare and increasing the risk of serious health complications hampering the market growth.

Covid-19 Impact

The COVID-19 pandemic significantly accelerated the demand for service robotics across various sectors. With increased emphasis on minimizing human contact and maintaining operational continuity, robots were rapidly deployed in healthcare, logistics, and disinfection services. In warehouses and retail, robots helped fulfill heightened e-commerce demands. This surge highlighted the value of robotics for efficiency and safety, driving long-term investment and innovation in service robotics post-pandemic.

The therapeutics segment is expected to be the largest during the forecast period

The therapeutics segment is estimated to be the largest, due to the increasing adoption of anti-infective drugs, vaccines, pain relievers, and regenerative therapies. This growth is driven by increased investment in disease prevention and treatment options by horse owners and facilities. Therapeutics also plays a crucial role in disease control and prevention, supporting herd health and reducing costly outbreaks.

The lyme disease segment is expected to have the highest CAGR during the forecast period

The lyme disease segment is anticipated to witness the highest CAGR during the forecast period, because lyme disease in horses requires complex diagnostic procedures, including serological assays like ELISA and confirmatory tests like Western blot or immunofluorescence assays. Advanced diagnostic tools like the Equine Lyme Multiplex Assay improve early detection and accuracy, crucial for effective treatment. Thus market growth is driven by the need for comprehensive diagnostic services and increased awareness among horse owners about Lyme disease.

Region with largest share:

Asia Pacific is expected to have the largest market share during the forecast period because the Asia Pacific, particularly China, Japan, and Australia, is experiencing a surge in equestrian sports, leading to a growing demand for equine healthcare products. This demand is driven by the growing participation in racing, show jumping, and polo, as well as the growing importance of therapeutic solutions like vaccines, anti-infectives, and supplements to address common equine health issues.

Region with highest CAGR:

North America is projected to witness the highest CAGR over the forecast period; access to expert equine doctors, clinics, and hospitals is made possible by the strong veterinary care infrastructure in North America. By providing specialized, high-quality care, this expands the market. The rising demand for horse diseases including tetanus, equine influenza, and West Nile virus is also driving a large investment in preventive treatment, including vaccines, deworming products, and supplements.

Key players in the market

Some of the key players profiled in the Equine Healthcare Market include Arthrex Inc., Boehringer Ingelheim International GmbH, Cargill, Ceva Sante Animale, Covetrus Inc., Dechra Pharmaceuticals, Elanco, Esaote SPA, Hallmarq Veterinary Imaging, Heska Corporation, IDEXX Laboratories, Inc., Kyoritsuseiyaku Corporation, Merck & Co. Inc, Neogen Corporation, Purina Animal Nutrition LLC., Vetoquinol S.A. and Zoetis

Key Developments:

In November 2024, Merck announced that Merck has entered into an exclusive global license to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova.

In October 2024, Gilead and Merck announced Phase 2 Data Showing a Treatment Switch to an Investigational Oral Once-Weekly Combination Regimen of Islatravir and Lenacapavir Maintained Viral Suppression in Adults at Week 48.

In October 2024, Cargill launched new cocoa production line in Indonesia to meet growing Asian consumers' demand for indulgent foods. The new line brings innovation capabilities and competitiveness to customers in the bakery, ice cream and chocolate confectionery categories, as well as for the cafe-style beverages in foodservice.

Product Types Covered:

  • Therapeutics
  • Diagnostics
  • Supplemental Nutrition
  • Other Product Types

Animal Types Covered:

  • Performance Horses
  • Recreational Horses
  • Working Horses
  • Racehorses
  • Other Animal Types

Disease Types Covered:

  • Equine Influenza
  • Lyme Disease
  • Tetanus
  • Rabies
  • Equine Encephalomyelitis
  • Musculoskeletal Disorders
  • West Nile Virus
  • Rabies
  • Other Disease Types

Distribution Channels Covered:

  • Veterinary Hospitals & Clinics
  • E-Commerce
  • Retail Pharmacies & Drug Stores
  • Other Distribution Channels

End Users Covered:

  • Veterinary Hospitals
  • Animal Clinics
  • Research Institutes
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Equine Healthcare Market, By Product Type

  • 5.1 Introduction
  • 5.2 Therapeutics
    • 5.2.1 Vaccines
    • 5.2.2 Anti-Infective Agents
    • 5.2.3 Parasiticides
    • 5.2.4 Anti-Inflammatory Drugs
  • 5.3 Diagnostics
    • 5.3.1 Clinical Pathology
    • 5.3.2 Immunoassays
    • 5.3.3 Molecular Diagnostics
    • 5.3.4 Imaging Techniques
  • 5.4 Supplemental Nutrition
    • 5.4.1 Feed Additives
    • 5.4.2 Performance Supplements
  • 5.5 Other Product Types

6 Global Equine Healthcare Market, By Animal Type

  • 6.1 Introduction
  • 6.2 Performance Horses
  • 6.3 Recreational Horses
  • 6.4 Working Horses
  • 6.5 Racehorses
  • 6.6 Other Animal Types

7 Global Equine Healthcare Market, By Disease Type

  • 7.1 Introduction
  • 7.2 Equine Influenza
  • 7.3 Lyme Disease
  • 7.4 Tetanus
  • 7.5 Rabies
  • 7.6 Equine Encephalomyelitis
  • 7.7 Musculoskeletal Disorders
  • 7.8 West Nile Virus
  • 7.9 Rabies
  • 7.10 Other Disease Types

8 Global Equine Healthcare Market, By Distribution Channel

  • 8.1 Introduction
  • 8.2 Veterinary Hospitals & Clinics
  • 8.3 E-Commerce
  • 8.4 Retail Pharmacies & Drug Stores
  • 8.5 Other Distribution Channels

9 Global Equine Healthcare Market, By End User

  • 9.1 Introduction
  • 9.2 Veterinary Hospitals
  • 9.3 Animal Clinics
  • 9.4 Research Institutes
  • 9.5 Other End Users

10 Global Equine Healthcare Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Arthrex Inc.
  • 12.2 Boehringer Ingelheim International GmbH
  • 12.3 Cargill
  • 12.4 Ceva Sante Animale
  • 12.5 Covetrus Inc.
  • 12.6 Dechra Pharmaceuticals
  • 12.7 Elanco
  • 12.8 Esaote SPA
  • 12.9 Hallmarq Veterinary Imaging
  • 12.10 Heska Corporation
  • 12.11 IDEXX Laboratories, Inc.
  • 12.12 Kyoritsuseiyaku Corporation
  • 12.13 Merck & Co. Inc
  • 12.14 Neogen Corporation
  • 12.15 Purina Animal Nutrition LLC.
  • 12.16 Vetoquinol S.A.
  • 12.17 Zoetis

List of Tables

  • Table 1 Global Equine Healthcare Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Equine Healthcare Market Outlook, By Product Type (2022-2030) ($MN)
  • Table 3 Global Equine Healthcare Market Outlook, By Therapeutics (2022-2030) ($MN)
  • Table 4 Global Equine Healthcare Market Outlook, By Vaccines (2022-2030) ($MN)
  • Table 5 Global Equine Healthcare Market Outlook, By Anti-Infective Agents (2022-2030) ($MN)
  • Table 6 Global Equine Healthcare Market Outlook, By Parasiticides (2022-2030) ($MN)
  • Table 7 Global Equine Healthcare Market Outlook, By Anti-Inflammatory Drugs (2022-2030) ($MN)
  • Table 8 Global Equine Healthcare Market Outlook, By Diagnostics (2022-2030) ($MN)
  • Table 9 Global Equine Healthcare Market Outlook, By Clinical Pathology (2022-2030) ($MN)
  • Table 10 Global Equine Healthcare Market Outlook, By Immunoassays (2022-2030) ($MN)
  • Table 11 Global Equine Healthcare Market Outlook, By Molecular Diagnostics (2022-2030) ($MN)
  • Table 12 Global Equine Healthcare Market Outlook, By Imaging Techniques (2022-2030) ($MN)
  • Table 13 Global Equine Healthcare Market Outlook, By Supplemental Nutrition (2022-2030) ($MN)
  • Table 14 Global Equine Healthcare Market Outlook, By Feed Additives (2022-2030) ($MN)
  • Table 15 Global Equine Healthcare Market Outlook, By Performance Supplements (2022-2030) ($MN)
  • Table 16 Global Equine Healthcare Market Outlook, By Other Product Types (2022-2030) ($MN)
  • Table 17 Global Equine Healthcare Market Outlook, By Animal Type (2022-2030) ($MN)
  • Table 18 Global Equine Healthcare Market Outlook, By Performance Horses (2022-2030) ($MN)
  • Table 19 Global Equine Healthcare Market Outlook, By Recreational Horses (2022-2030) ($MN)
  • Table 20 Global Equine Healthcare Market Outlook, By Working Horses (2022-2030) ($MN)
  • Table 21 Global Equine Healthcare Market Outlook, By Racehorses (2022-2030) ($MN)
  • Table 22 Global Equine Healthcare Market Outlook, By Other Animal Types (2022-2030) ($MN)
  • Table 23 Global Equine Healthcare Market Outlook, By Disease Type (2022-2030) ($MN)
  • Table 24 Global Equine Healthcare Market Outlook, By Equine Influenza (2022-2030) ($MN)
  • Table 25 Global Equine Healthcare Market Outlook, By Lyme Disease (2022-2030) ($MN)
  • Table 26 Global Equine Healthcare Market Outlook, By Tetanus (2022-2030) ($MN)
  • Table 27 Global Equine Healthcare Market Outlook, By Rabies (2022-2030) ($MN)
  • Table 28 Global Equine Healthcare Market Outlook, By Equine Encephalomyelitis (2022-2030) ($MN)
  • Table 29 Global Equine Healthcare Market Outlook, By Musculoskeletal Disorders (2022-2030) ($MN)
  • Table 30 Global Equine Healthcare Market Outlook, By West Nile Virus (2022-2030) ($MN)
  • Table 31 Global Equine Healthcare Market Outlook, By Rabies (2022-2030) ($MN)
  • Table 32 Global Equine Healthcare Market Outlook, By Other Disease Types (2022-2030) ($MN)
  • Table 33 Global Equine Healthcare Market Outlook, By Distribution Channel (2022-2030) ($MN)
  • Table 34 Global Equine Healthcare Market Outlook, By Veterinary Hospitals & Clinics (2022-2030) ($MN)
  • Table 35 Global Equine Healthcare Market Outlook, By E-Commerce (2022-2030) ($MN)
  • Table 36 Global Equine Healthcare Market Outlook, By Retail Pharmacies & Drug Stores (2022-2030) ($MN)
  • Table 37 Global Equine Healthcare Market Outlook, By Other Distribution Channels (2022-2030) ($MN)
  • Table 38 Global Equine Healthcare Market Outlook, By End User (2022-2030) ($MN)
  • Table 39 Global Equine Healthcare Market Outlook, By Veterinary Hospitals (2022-2030) ($MN)
  • Table 40 Global Equine Healthcare Market Outlook, By Animal Clinics (2022-2030) ($MN)
  • Table 41 Global Equine Healthcare Market Outlook, By Research Institutes (2022-2030) ($MN)
  • Table 42 Global Equine Healthcare Market Outlook, By Other End Users (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.